fashion -WSS

fashion

author：focus 2025-09-05 11:30:12 - browse：71338

Immunofluorescence image shows CD4+ (green) and CD8+ (yellow) T cells in the microenvironment of a head and neck squamous cell carcinoma. — This immunofluorescence image shows T cells (in green and yellow) in the microenvironment of a head and neck squamous cell carcinoma. Allen Lab/NCI/NIH

Merus said Tuesday that the combination of its experimental drug petosemtamab with the checkpoint inhibitor Keytruda shrank tumors in 62% of patients with head and neck cancer, according to an interim analysis of an ongoing mid-stage clinical trial.

The new efficacy results, derived from a larger number of patients, look similar to an initial disclosure made last week that triggered a 36% increase in Merus’ stock price.

But the Dutch drugmaker on Tuesday withheld additional information from the study related to the safety and durability of petosemtamab’s tumor responses, pending presentation at the annual meeting of the American Society of Clinical Oncology on June 3.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Cancer cells are shown to suck energy source from immune cells

Wikipedia

WSS

Alabama frozen embryo ruling has major implications for IVF clinics

New documents shed light on MD Anderson Cancer Institute feud

New documents shed light on MD Anderson Cancer Institute feud

Alabama frozen embryo ruling has major implications for IVF clinics

Takeaways from AdvaMed, the largest medical devices conference

How doctors and nurses shape Google's AI

leisure time

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

He's a Nobel laureate. Critics say he was misleading on Covid

Peter Hotez and the public health issue of online harassment

Nick Jonas talks about managing diabetes along with his career

In age of alternative facts, a scholarly course on calling out crap

Medicare inequities exacerbate Puerto Rico’s health disparities

Walensky prepares to leave CDC — and Congress — behind

A solution to the after

Hepatitis C has a cure — but many Americans still lack access to it

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

hotspot

A new nitrogen execution bill also undermines medical licensing

How should state employee insurance handle Wegovy?

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

A revolution in caring for preterm infants

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

Wellcome Trust names Røttingen as its new CEO

Wikipedia

focus

hotspot

knowledge